|Job Title||Palliative Care - Practice Development Lead (RGN) - EXPIRED|
|Salary||£37450 per annum|
|Job Published||02 Jan 2015|
|Contact Name||TPP Healthcare|
A not-for-profit provider of innovative, high quality care and support services based in Aylesbury and covering Buckinghamshire, Milton Keynes, Bedfordshire, Berkshire, Barnet, Harrow and Hertfordshire are currently recruiting for a Palliative Care Practice Development Lead on a full term and permanent basis.
The ideal candidate will have experience in End of Life Care and be looking to design and facilitate training and development opportunities for people working across the organisation's services to improve the end of life care.
The key purpose of this role is to contribute, through training and development work, to the improved knowledge, skill and practice, in end of life care, for the organisation's staff.
Essential criteria for the Palliative Care Development Practice Lead include:
Hold full NMC registration with a minimum 5 years post-registration experience
Experience of delivering end of life care
Evidence of education/training in end of life care
Mentorship & teaching qualification (ENB 998 or equivalent)
Knowledge of current end of life /palliative care issues
Knowledge and understanding of the professional roles & the contribution of the multi-professional teams providing end of life care
Ability to think strategically and beyond the immediate term and organisation/ job role.
Ability to develop positive working relationships
Ability to demonstrate initiative, motivation with a dynamic outlook.
Ability to work unsupervised
Possession of a valid, full UK driving licence and access to a vehicle, which can be used for work purposes
For more information please call 0207 198 6080
TPP is committed to equal opportunities and actively encourages applications from all sectors of the community. We shortlist based on competencies and not on race, religion, sex, physical or mental disability, or age.
TPP was voted Best Recruitment Agency 2014 at the IoF PIFAs.